Navigation Links
Evolving Market Access in the APAC Region, a New Xtalks Life Sciences Webinar
Date:3/28/2013

Toronto, Canada (PRWEB) March 28, 2013

As the pharmaceutical industry in the West is being challenged with austerity and increasing pricing pressure, companies have started looking to diversify their portfolios through emerging markets. The countries within emerging markets are highly diverse and business models need to be locally tailored to ensure success.

The aim of this webinar is to cover market access related issues in the Asia Pacific region, including Japan and China, representing the world’s second and third largest pharmaceutical markets. South Korea and Taiwan, also major reimbursement markets as well as innovators in biologics and specialty products, will also be discussed.

This session will cover:

Ongoing healthcare reform in China and its implication on access

  • Top level regulatory requirement overview
  • Market access in China: What are Reimbursement Drug List and Essential Drug List and how are prices set?
  • Pricing trends
  • Healthcare reform bill and the impact on distribution channels
  • How to address the affordability issue?

Pricing trends and price premiums in Japan

  • Pricing and access principles
  • Reward for innovation
  • The utility of health economics

HTA in the APAC region:

  • The adaptation of Health Technology Assessment (HTA) in Japan and China
  • The impact of HTA on reimbursement, pricing and access in S Korea and Taiwan

For more information about this event or to register, visit: http://xtks.in/ZnKQUb.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners t
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
9. GeneLink Marketing Efforts Poised to Show Results
10. Animal Biotechnology - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Surrey have discovered how the receptors responsible for contractions ... The new study, published today in The FASEB ... turn regulates the cycle of all cells in the ... local biological clock and its control are weakened in ... bladder physiology and ageing. , While currently ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Ophthalmic ... the interesting and challenging endeavors as the anatomy, ... impervious properties to the foreign substances. Ocular drug ... of self medication and minimal use of needles; ... weight drugs and provides specific targeting within the ...
(Date:8/22/2014)... August 22, 2014 The AMA is ... its members in Alaska that Alaska Governor Sean Parnell ... 15, further defining public use of Unmanned Aircraft Systems ... Force. House Bill 255states that it is, “An Act ... captured by an unmanned aircraft system.” It defines State ...
(Date:8/21/2014)... 2014  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® ... and XIAPEX ® in the EU, today ... double-blind Phase 2a study of CCH for the ... The results showed that all three doses of ...
Breaking Biology Technology:Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4State of Alaska Signs Unmanned Aircraft Systems Bill 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5
... DIEGO, Sept. 9 Orexigen((R) )Therapeutics, Inc. (Nasdaq: OREX ), a ... will be speaking at two upcoming investor conferences. The details are as ... Stanley Global Healthcare Unplugged Conference, Date: September 15, 2009, ... Grand Hyatt Hotel, New York, Speaker: Michael Narachi, President ...
... TAI,AN, China, Sept. ... Bulletin Board: CBPO) ("China Biologic," or the ... in the People,s,Republic of China ("PRC"), operating ... Products Co. Ltd. ("Taibang") and,Chongqing Dalin Biologic ...
... , , THE WOODLANDS, ... LXRX ), a biopharmaceutical company focused on discovering and developing ... Sands, M.D., Ph.D. , Lexicon,s president and chief executive officer, will ... Hyatt hotel in New York, New York on Tuesday, September 15, 2009 ...
Cached Biology Technology:China Biologic Products Appoints Director of Research and Development 2China Biologic Products Appoints Director of Research and Development 3Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2
(Date:8/22/2014)... and clinical research and technological advances, the fight ... spanning multiple fronts. , Work happening in a ... new and more selective therapies for cancer. Researchers ... enzyme overexpressed in certain cancersand they have tested ... Chemistry professor Christopher Cairo and his team synthesized ...
(Date:8/22/2014)... of captive black rhino reproduction in Europe highlights ... breeding programmes. , Researchers from Chester Zoo, The ... carried out a six-year study which encompassed 90% ... Katie Edwards led the research as part of ... says: "Although some black rhinoceros breed well in ...
(Date:8/22/2014)... is a multifunctional enzyme that localizes ... neuroprotective and cholesterol-synthesizing activities. DHCR24 overexpression ... amyloid β deposition. Dr. Xiuli Lu ... China constructed two recombinant adenoviruses (Ad-rSYN1-DHCR24-myc ... specifically in neuronal cells. They also ...
Breaking Biology News(10 mins):New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3Hormone analysis helps identify horny rhinos 2
... increases resulting from climate change in the Southwest will likely ... in 60 to 90 years, according to a new study ... research team used models of future climate, an analysis of ... and the fossil record to project the future distribution of ...
... on Osteoporosis & Osteoarthritis by investigators from the UK ... fractures in five major European countries totals 31 billion ... of the economic burden is shown to be related ... the fracture, while pharmacological prevention and treatment management constitutes ...
... Researchers with the Los Angeles County Department of Public ... pathogen, carbapenem-resistant Klebsiella pneumoniae (CRKP) among the patient population ... care hospitals across the county. These findings are ... to East Coast facilities and communities. These findings will ...
Cached Biology News:Uncertain future for Joshua trees projected with climate change 2Drug-resistant pathogen found in large numbers in LA County 2
Mouse Amphiregulin MAb (Clone 206220)...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
The antibody recognizes the peptide sequence ESESQGPK (aa 441-448) of human class III beta-tubulin specific for neurones....
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
Biology Products: